Growth Metrics

Neuroone Medical Technologies (NMTC) Liabilities from Discontinued Operations (2015 - 2016)

Neuroone Medical Technologies posted quarterly Liabilities from Discontinued Operations of 21807.0 for Q4 2016, up 10.02% year-on-year from 19821.0 in Q1 2016, and little changed on a QoQ basis from 21807.0 in Q3 2016.

Neuroone Medical Technologies (NMTC) has 2 years of Liabilities from Discontinued Operations data on file, last reported at 21807.0 in Q4 2016.

  • For the quarter ending Q4 2016, Liabilities from Discontinued Operations rose 10.02% year-over-year to 21807.0; the trailing twelve-month figure through Dec 2016 stood at 21807.0 (up 10.02% YoY), and the FY2016 full-year result was 21807.0, up 10.02% from the prior year.
  • Liabilities from Discontinued Operations for Q4 2016 stood at 21807.0, roughly flat from 21807.0 in the prior quarter.
  • Across five years, Liabilities from Discontinued Operations topped out at 21807.0 in Q2 2016 and bottomed at 19821.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Neuroone Medical Technologies 31.39 Mn 28.59 Mn 1.29 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2016 21,807.00
Dec 31, 2016 21,807.00
Sep 30, 2016 21,807.00
Sep 30, 2016 21,807.00
Jun 30, 2016 21,807.00
Jun 30, 2016 21,807.00
Dec 31, 2015 19,821.00
Dec 31, 2015 19,821.00